Condition
Enteral and Supplement Feeds Adverse Reaction
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed3
Unknown2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05347888CompletedPrimary
How Well do we Feed the Critically Ill Patients
NCT06095804Not ApplicableUnknown
Clinical Pilot Study of the Percutaneous Ultrasound Jejunostomy Procedure
NCT05997745Not ApplicableUnknownPrimary
Enteral Nutrition in Acute Generalized Peritonitis
NCT05204901Not ApplicableCompletedPrimary
Using Magnetic Field Tracking to Confirm Nasogastric Tube Placement at Point of Care
NCT05815849Not ApplicableCompleted
Effect of Enteral Olive Oil Supplement On Weight Gain and Development of Some Complications in Preterm
Showing all 5 trials